MetLife Hong Kong Launches its First Critical Illness Reimbursement Product

MetLife
Health Selection Critical Care Plan offers value-for-money comprehensive reimbursement
for most common critical
illnesses

�

HONG KONG, CHINA – Media OutReach - November 28, 2018
- MetLife Hong Kong*
announced the launch of its brand-new MetLife Health Selection Critical Care
Plan, designed to reimburse diagnosis costs, treatment and other eligible
expenses up to a lifetime limit of HK$12 million for the most common critical
illnesses: cancer (including carcinoma-in-situ), heart attack, stroke and
kidney failure.

 

MetLife
Hong Kong announced the launch of its brand-new MetLife Health Selection
Critical Care Plan. (Left to right: Eva
Wong, Chief Agency Officer, and Vincent Chan, Head of Product
of MetLife Hong Kong)

  

“MetLife Hong Kong
has always kept a close eye on health trends and customer needs. In view of the
increasing risk of critical illnesses striking at a younger age, we have designed
MetLife Health Selection Critical Care Plan as an innovative, value-for-money
solution tailored to the needs of the younger generation and the mass market,”
said Mr. Vincent Chan, Head of Product of MetLife Hong Kong.

 

“Traditional critical illness insurance products
typically support medical treatment by providing a lump sum payment in a set
amount for one-off financial support. But as new treatments and medications
emerge, the average coverage that most people currently have under existing
critical illness policies may well be inadequate. That’s why we have gone
beyond the typical critical illness insurance in developing this specific critical
illness reimbursement product. We have crafted this product to provide a high
level of coverage at a very affordable premium, creating greater value for
customers. The plan offers comprehensive reimbursement for both traditional and
new critical illness treatment methods (including non-Hong Kong registered
medication for cancer treatment), and covers recurrence, metastasis and
persistence of cancer. In this manner, we are fully supporting customers along
the pathway of life.”

 

Key features of MetLife
Health Selection Critical Care Plan include:

• First-in-market critical illness reimbursement
  plan that covers kidney failure— The plan covers cancer (including carcinoma-in-situ), heart attack, stroke
  and kidney failure.
• Affordable premiums— By paying as low as
  around HK$3 a day^#, customers can receive reimbursement for eligible
  medical expenses of up to HK$2 million for each occurrence of a covered
  disease, subject to a lifetime limit of HK$12 million.
• Comprehensive reimbursement— The plan reimburses expenses for diagnosis, traditional treatments and new treatments, recovery progress monitoring and other
  eligible items.
• Continued protection— Claims for multiple covered diseases are allowed. The
  plan also replenishes the covered disease limit for persisting cancer every 3 years.
• Extended care— The plan covers
  expenses for complete surgical excision of covered benign tumors^ and
  alternative treatments such as acupuncture and physiotherapy.
• 2-year premium waiver— The plan waives premiums for 2 years upon diagnosis of a
  covered disease (including carcinoma-in-situ) for the first time.
• Guaranteed renewal— The plan is guaranteed renewable up to age 100 of the
  insured person.

 

Across
Asia, MetLife is steadily building out a combination of insurance solutions and
services to help customers better understand how to prevent and manage serious
illnesses under an offering called 360 Health.

 

Ms. Eva
Wong, Chief Agency Officer of MetLife Hong Kong, said, “Being customer centric
is a commitment we have made at MetLife Hong Kong. As our customers’ trusted advisor, we are
dedicated to providing quality insurance coverage for customers and supporting
them in pursuit of a better life. With our talented workforce, top-notch financial
strength, innovative products and differentiated brand, MetLife Hong Kong will
continue to grow and to provide greater value for our customers, in tandem with
our ongoing commitment to navigating life together with them.”

 

MetLife
Hong Kong has also launched the “MetLife 150^th Anniversary Health
& Wealth Rewards”. From now till December 31, 2018, customers who
successfully apply for MetLife Health Selection Critical Care Plan or MetLife
Health Selection Critical Care Benefit can enjoy a one-month premium discount⁺.

 

For further details about MetLife Health Selection
Critical Care Plan, please visit: www.metlife.com.hk/en/customer/healthselection

 

^# The required premium amount is based on an example of a 25-year-old
non-smoking male insured person who is in good health, and the assumptions that
Critical Illness Inclusive Plan — Premier is applied and an annual premium
payment mode is selected. Premium payable is calculated according to the
insured person’s attained age, sex, smoking habit and the applicable premium
rate at the time of application or renewal. The figure is for reference only
and may differ slightly from other illustration documents due to rounding
differences.

^ Covers
complete surgical excision of a solid tumor to rule out cancer.

⁺ Terms
and conditions apply. For further details, please refer to the relevant
promotion leaflet.

 

The above information is intended for
reference only. Please refer to the relevant Policy Provisions of MetLife Health Selection Critical Care Plan for definitions,
detailed terms, conditions and exclusions.

About
MetLife

MetLife, Inc. (NYSE: MET), through its
subsidiaries and affiliates (“MetLife”), is one of the world’s leading
financial services companies, providing insurance, annuities, employee benefits
and asset management to help its individual and institutional customers
navigate their changing world. Founded in 1868, MetLife has operations in more
than 40 countries and holds leading market positions in the United States,
Japan, Latin America, Asia, Europe and the Middle East. For more information,
visit www.metlife.com.

 

^* MetLife Limited and Metropolitan Life Insurance
Company of Hong Kong Limited (collectively “MetLife Hong Kong”) are
wholly-owned subsidiaries of MetLife, Inc. in Hong Kong and private companies
limited by shares incorporated and registered under the applicable laws in Hong
Kong. Both MetLife Limited and Metropolitan Life Insurance Company of Hong Kong
Limited are authorized insurers carrying long term business in Hong Kong.